文献速递妇科

腹腔镜输尿管膀胱再植术治疗输尿管子宫内膜异位症:160例连续病例的单中心经验

Total Laparoscopic Ureteroneocystostomy for Ureteral Endometriosis: A Single-Center Experience of 160 Consecutive Patients.
PubMed 文献 · J Minim Invasive Gynecol · 2018-04-12

本研究为前瞻性研究(加拿大任务组分类II-2),纳入2009年1月至2016年12月间160例深部浸润型子宫内膜异位症(DIE)累及输尿管、宫旁及肠道者,行腹腔镜保留神经根治性切除及输尿管膀胱再植术。结果显示症状较术前显著改善(P<.001),宫旁子宫内膜异位症复发率1.2%。作者认为该技术可行、有效且安全。

要点

  • 160例DIE患者行腹腔镜根治性切除及输尿管膀胱再植术,输尿管子宫内膜异位症均经组织学确诊(内源性45.6%、外源性54.4%)。
  • 58.7%采用腰大肌悬吊技术完成输尿管膀胱再植;75.6%行肠段切除,其中71.9%同时行回肠造口。
  • 术后6个月膀胱排空障碍发生率为15%,再次手术4.4%,症状较术前显著改善(P<.001)。

核心结论

  • 作者认为,对输尿管子宫内膜异位症患者,腹腔镜根治性切除及输尿管膀胱再植术可行、有效且安全,在复发和症状控制方面结果良好。
  • 这是目前文献中规模最大的DIE患者行腹腔镜根治性切除及输尿管膀胱再植术的系列。

研究设计与样本

  • 前瞻性研究,加拿大任务组分类II-2,在子宫内膜异位症三级转诊中心开展。
  • 纳入2009年1月至2016年12月间160例DIE患者,均行腹腔镜保留神经根治性治疗及输尿管膀胱再植术,必要时行宫旁切除和肠段切除。
  • 平均随访时间20.5个月(范围1-60个月)。

主要发现

  • 输尿管子宫内膜异位症均经组织学确诊,内源性占45.6%、外源性占54.4%。
  • 58.7%的患者采用腰大肌悬吊技术完成输尿管膀胱再植术。
  • 121例(75.6%)行肠段切除,其中115例(71.9%)同时行回肠造口。
  • 单侧宫旁切除左侧占61.9%、右侧占30%,双侧宫旁切除33例(20.6%)。
  • 术后并发症:再次手术7例(4.4%)、发热8例(5%)、需输血4例(2.5%)、肠瘘3例(1.9%)、术后6个月膀胱排空障碍24例(15%)。

临床怎么用

  • 作者认为,对输尿管子宫内膜异位症患者,腹腔镜根治性切除及输尿管膀胱再植术可行、有效且安全,在复发和症状控制方面结果良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To investigate the efficacy of laparoscopic ureteroneocystostomy in patients with deep infiltrating endometriosis (DIE) with ureteral, parametrial, and bowel involvement. DESIGN: Prospective study (Canadian Task Force classification II-2). SETTING: Tertiary referral center for endometriosis care. PATIENTS: One hundred sixty patients with DIE underwent laparoscopic radical eradication and ureteroneocystostomy between January 2009 and December 2016. INTERVENTIONS: Laparoscopic nerve-sparing radical treatment with ureteroneocystostomy, parametrectomy, and, if necessary, segmental bowel resection. MEASUREMENTS AND MAIN RESULTS: Surgical eradication was radical, and ureteral endometriosis was histologically confirmed in all patients (45.6% intrinsic and 54.4% extrinsic). In 58.7% of patients ureteroneocystostomy was performed with the psoas hitch technique. Bowel resection was performed in 121 patients (75.6%), and 115 of them had a concomitant ileostomy (71.9%). Unilateral parametrectomy was performed on the left side in 61.9% of patients and on the right side in 30% of patients, respectively, whereas bilateral parametrectomy was completed in 33 patients (20.6%). Postoperative complications were infrequent: 7 patients underwent reoperation (4.4%), 8 patients experienced fever (5%), 4 patients required blood transfusion (2.5%), 3 patients had intestinal fistulas (1.9%), and 24 patients experienced impaired bladder voiding (15%) after 6 months. Mean follow-up time was 20.5 months (range, 1-60). The study reported good clinical and surgical results, with a regression of symptoms (p < .001) and recurrence of parametrial endometriosis of 1.2% that required opposite-side ureteroneocystostomy. CONCLUSION: This is the largest documented series of patients with DIE undergoing laparoscopic radical eradication and ureteroneocystostomy. The collected data show that in patients with ureteral endometriosis, this technique is feasible, effective, and safe and provides good results in terms of relapses and symptoms' control.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Ceccaroni M, Ceccarello M, Caleffi G, et al. Total Laparoscopic Ureteroneocystostomy for Ureteral Endometriosis: A Single-Center Experience of 160 Consecutive Patients. J Minim Invasive Gynecol. 2018. PMID: 29656149. doi:10.1016/j.jmig.2018.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。